She is graduated in Biochemistry and Biomedical Sciences by the University of Valencia (2014-2018 promotion). During her last year at University, being beneficiary of an “Asociación Española Contra el Cáncer” (AECC) Scholarship, she was working at the “Molecular Basis Unit of Neurodegeneration” located at the Institute of Biomedicine of Valencia (IBV-Spanish Research Council) and led by Dr. Marçal Vilar Cerveró (PhD). As a CICERONE Fellow, obtained in 2018, Ana started her stay at Spanish National Center for Cardiovascular Research (CNIC), taking part of “Cardiac Arrhythmia” Laboratory led by Dr. José Jalife (MD, PhD). She coursed the Interuniversity Master in Genetics and Cell Biology provided by the Autonomous University of Madrid, Complutense University of Madrid, and University of Alcalá de Henares. As a CNIC-MASTER Fellow and under the guidance of Dr. Jalife, Ana carried out a master thesis focused on the molecular and electrocardiographic characterization of murine and human models of Andersen-Tawil Syndrome Type 1 (ATS1). Since then, she remains a member of the CNIC “Cardiac Arrhythmia” group and is now studing the arrhythmogenic and molecular basis of Short QT Syndrome Type 3 (SQTS3), an extremely rare and lethal channelopathy caused by mutations in the inward rectifying potassium channel Kir2.1.
